Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Miku Anzai"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract This study was conducted to examine times to onset, incidence rates, and outcomes of nivolumab-induced lung adverse events (AEs), using the Japanese Adverse Drug Event Report database. We analysed data for the period between April 2004 and M
Externí odkaz:
https://doaj.org/article/dc3ba449d39c47a0a99fbc6a99beb838
Purpose: Nivolumab has been widely used in patients since its launch, but detailed information on lung-specific adverse events (AEs) from post-marketing monitoring has not been reported. We therefore conducted this study to examine times to onset, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a72a9faab8a695329e4a46697a95b96d
https://doi.org/10.21203/rs.3.rs-2471812/v1
https://doi.org/10.21203/rs.3.rs-2471812/v1
The present study aimed to determine the risk of nivolumab-induced cardiac adverse events (AEs), time to onset, incidence rates, and post hoc outcomes using the Japanese Adverse Drug Event Report database. We analyzed data for the period between Apri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3d65110dd815c60aa6c1007e5d3a751
https://doi.org/10.21203/rs.3.rs-2050199/v1
https://doi.org/10.21203/rs.3.rs-2050199/v1